Repligen Corporation (RGEN) Narrowly Beats Estimates, Posts Q2 3c Loss

November 5, 2009 8:09 AM EST

Repligen Corporation (NASDAQ: RGEN) reports Q2 loss of $0.03, 1 cent better than the analyst estimate of ($0.04). Revenue for the quarter was $5.42 million, which compares to the estimate of $5.19 million.


Related Categories

Earnings

Stocks Mentioned

RGEN 4.80

+0.04 +0.84%
Volume: 92,387
Track RGEN


Add Your Comment